{
  "ptid_time": "114_S_0173_2016-02-05",
  "img_path": "/data/qiuhui/data/adni/images/114_S_0173/2016-02-05/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 85,051 mm³, 80.9% above the reference mean. With a Z-score of 2.35 (99.1th percentile), this represents significant enlargement; hippocampal volume measures 6,079 mm³, 12.8% below the reference mean. With a Z-score of -1.10 (13.5th percentile), this represents mild atrophy; whole brain volume measures 1,041,250 mm³, 1.2% above the reference mean. With a Z-score of 0.15 (56.1th percentile), this represents normal volume ; entorhinal cortex volume measures 2,679 mm³, 32.5% below the reference mean. With a Z-score of -2.13 (1.7th percentile), this represents significant atrophy; fusiform gyrus volume measures 17,648 mm³, 2.3% below the reference mean. With a Z-score of -0.20 (42.1th percentile), this represents normal volume ; middle temporal gyrus volume measures 20,622 mm³, 2.2% above the reference mean. With a Z-score of 0.20 (57.9th percentile), this represents normal volume . ",
  "text_data": "Age is 83.2 years. Gender is Male. Education: 18 years. MMSE: 27.0. MoCA: 22.0. Logical Memory: 1.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.45 SUVR (significant elevated); Amyloid beta: 628.20 pg/mL (mild reduced); Total tau: 313.60 pg/mL (normal ); Phosphorylated tau: 31.44 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant ventricular enlargement (Z-score 2.35) and entorhinal cortex atrophy (Z-score -2.13), along with mild hippocampal atrophy (Z-score -1.10), which are consistent with neurodegenerative changes. The MoCA score of 22 suggests mild cognitive impairment, while the MMSE of 27 is borderline normal, indicating possible early cognitive decline. Elevated AV45 (amyloid PET) and mildly reduced Aβ with elevated P-tau support an Alzheimer’s-like pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**, likely due to Alzheimer’s disease.  \n\n**Confidence:** **Medium** (clinical scores are borderline, but imaging and biomarkers strongly suggest early neurodegeneration).",
  "timestamp": "2025-07-26T11:39:02.103065"
}